phenyl acetate has been researched along with Acute Bacterial Prostatitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosland, MC; Said, MM | 1 |
Schulman, CC; Simon, J | 1 |
Iljin, II; Kobelev, AA; Kovalev, JN | 1 |
1 trial(s) available for phenyl acetate and Acute Bacterial Prostatitis
Article | Year |
---|---|
[Chronic prostatitis in venereological practice. II. Etiotropic and pathogenetic therapy].
Topics: Acetates; Adult; Animals; Anti-Bacterial Agents; Chronic Disease; Clinical Trials as Topic; Cortisone; Humans; Hydrocortisone; Injections; Male; Middle Aged; Prostatitis; Rabbits | 1972 |
2 other study(ies) available for phenyl acetate and Acute Bacterial Prostatitis
Article | Year |
---|---|
The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; E-Selectin; Estradiol; Gene Expression Regulation; Inflammation Mediators; Interleukin-6; Leukotriene Antagonists; Leukotriene B4; Male; NF-kappa B; Nitric Oxide Synthase Type II; Orchiectomy; Prostate; Prostatitis; Quinolines; Rats, Wistar; Receptors, Leukotriene; Sulfides; Time Factors; Tumor Necrosis Factor-alpha | 2017 |
[Treatment of inflammatory disease of the prostate with non-steroid anti-inflammatory agents].
Topics: Acetates; Anti-Inflammatory Agents; Humans; Male; Prostatic Hyperplasia; Prostatitis; Thiazoles | 1983 |